WILLIAM E. ROTE
CIK 1698262 · Chief Research Officer · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.77M
Companies
2
Total Filings
61
Lifetime Open-Market Net
-$5.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Chief Research Officer | 118,237 | $65.71 | $7.77M | -$4.65M | 28 | 2026-05-06 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Senior Vice President, R&D | 24,086 | — | — | -$567.0K | 19 | 2020-11-17 |
Recent Filings · Page 3 of 7
61 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-01 | TVTX | Notice (144) | −2,590 | -$22.9K | EDGAR |
| 2024-02-01 | TVTX | Notice (144) | −2,174 | -$18.5K | EDGAR |
| 2024-01-25 | TVTX | Sell (S) | −2,062 | -$18.5K | EDGAR |
| 2024-01-23 | TVTX | Notice (144) | −2,062 | -$18.5K | EDGAR |
| 2023-09-05 | TVTX | Notice (144) | −1,815 | -$26.7K | EDGAR |
| 2023-09-05 | TVTX | Mixed | +1,485 | -$26.7K | EDGAR |
| 2023-05-12 | TVTX | Sell (S) | −825 | -$13.7K | EDGAR |
| 2023-05-10 | TVTX | Notice (144) | −825 | -$13.7K | EDGAR |
| 2023-02-02 | TVTX | Mixed | +17,660 | -$57.6K | EDGAR |
| 2023-01-26 | TVTX | Sell (S) | −2,062 | -$44.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.